Safety and immunogenicity of a booster dose of Vibrio cholerae CVD 103-HgR live oral cholera vaccine in Swiss adults.

Documenti analoghi

• Potential for reacquisition of cholera enterotoxin genes by attenuated Vibrio cholerae vaccine strain CVD 103-HgR.
  di: Kaper, J B, et al.
  Pubblicazione: (1994)
• Safety and immunogenicity of a live oral bivalent typhoid fever (Salmonella typhi Ty21a)-cholera (Vibrio cholerae CVD 103-HgR) vaccine in healthy adults.
  di: Cryz, S J, et al.
  Pubblicazione: (1995)
• Diminished immunogenicity of a recombination-deficient derivative of Vibrio cholerae vaccine strain CVD103.
  di: Ketley, J M, et al.
  Pubblicazione: (1990)
• Evaluation of a bivalent (CVD 103-HgR/CVD 111) live oral cholera vaccine in adult volunteers from the United States and Peru.
  di: Taylor, D N, et al.
  Pubblicazione: (1997)
• Safety and immunogenicity in North Americans of a single dose of live oral cholera vaccine CVD 103-HgR: results of a randomized, placebo-controlled, double-blind crossover trial.
  di: Kotloff, K L, et al.
  Pubblicazione: (1992)